An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions. - Joshi S; Gudi G; Menon VCA; Tandon M; Joshi V; Suryawanshi S; Barkate H; Sawant N; Katare S; Siddique W (Clinical pharmacokinetics, 2020)